125 related articles for article (PubMed ID: 9972775)
1. Severe anaphylactic reaction to cisatracurium.
Toh KW; Deacock SJ; Fawcett WJ
Anesth Analg; 1999 Feb; 88(2):462-4. PubMed ID: 9972775
[No Abstract] [Full Text] [Related]
2. Cisatracurium and atracurium as antigens.
Fisher MM
Anaesth Intensive Care; 1999 Aug; 27(4):369-70. PubMed ID: 10470390
[TBL] [Abstract][Full Text] [Related]
3. Anaphylactic reaction after cisatracurium.
Clendenen SR; Harper JV; Wharen RE; Guarderas JC
Anesthesiology; 1997 Sep; 87(3):690-2. PubMed ID: 9316977
[No Abstract] [Full Text] [Related]
4. Anaphylactic reaction after cisatracurium administration.
Iannuzzi E; Iannuzzi M; Pedicini MS; Cirillo V; Chiefari M; Sacerdoti G
Eur J Anaesthesiol; 2002 Sep; 19(9):691-3. PubMed ID: 12243298
[No Abstract] [Full Text] [Related]
5. [Type IV anaphylactic reaction and ST-elevation acute coronary syndrome due to coronary vasospasm secondary to administration of cisatracurium].
Benítez Morillo MF; Casares Vivas M; Tejada Ruiz FJ; Narváez Bermejo JM
Med Intensiva; 2008; 32(5):260-1. PubMed ID: 18570839
[No Abstract] [Full Text] [Related]
6. Acute coronary syndrome in cisatracurium-induced anaphylactic shock: Kounis syndrome.
Yang YL; Huang HW; Yip HK; Jawan B; Tseng CC; Lu HF
Acta Anaesthesiol Taiwan; 2008 Dec; 46(4):184-6. PubMed ID: 19097966
[TBL] [Abstract][Full Text] [Related]
7. Immediate-type reactions to cisatracurium.
Hunzelmann N; Kopner R; Hani N; Scharffetter-Kochanek K
Allergy; 1999 Nov; 54(11):1227-8. PubMed ID: 10604564
[No Abstract] [Full Text] [Related]
8. Anaphylactoid reactions after cisatracurium administration in six patients.
Krombach J; Hunzelmann N; Köster F; Bischoff A; Hoffmann-Menzel H; Buzello W
Anesth Analg; 2001 Nov; 93(5):1257-9, table of contents. PubMed ID: 11682408
[TBL] [Abstract][Full Text] [Related]
9. Possible underestimation of the relative incidence of anaphylactic reactions to benzylisoquinoline neuromuscular blocking agents.
Lagneau F; Corda B; Marty J
Eur J Anaesthesiol; 2003 Jul; 20(7):577-8. PubMed ID: 12884994
[No Abstract] [Full Text] [Related]
10. Severe anaphylactic reaction to cisatracurium in a child.
Legros CB; Orliaguet GA; Mayer MN; Labbez F; Carli PA
Anesth Analg; 2001 Mar; 92(3):648-9. PubMed ID: 11226094
[No Abstract] [Full Text] [Related]
11. Anaphylaxis to cisatracurium following negative skin testing.
Fraser BA; Smart JA
Anaesth Intensive Care; 2005 Dec; 33(6):816-9. PubMed ID: 16398392
[TBL] [Abstract][Full Text] [Related]
12. A severe anaphylactic reaction to atracurium.
Mercer JD
Anaesth Intensive Care; 1984 Aug; 12(3):262-3. PubMed ID: 6549108
[No Abstract] [Full Text] [Related]
13. Early diagnosis of an allergic reaction to cisatracurium.
Goikoetxea MJ; Lafuente A; de la Borbolla JM; Moncada R; Sanz ML; Gastaminza G
J Investig Allergol Clin Immunol; 2013; 23(1):69-71. PubMed ID: 23653984
[No Abstract] [Full Text] [Related]
14. Persistent anaphylactic reaction after induction with thiopentone and cisatracurium.
Briassoulis G; Hatzis T; Mammi P; Alikatora A
Paediatr Anaesth; 2000; 10(4):429-34. PubMed ID: 10886702
[TBL] [Abstract][Full Text] [Related]
15. Serious bronchospasm induced by cisatracurium besylate: A case report.
Wang N; Zhang Y; Hu Y; Yang Q; Su Z
Medicine (Baltimore); 2021 Apr; 100(15):e25516. PubMed ID: 33847670
[TBL] [Abstract][Full Text] [Related]
16. [Value of skin tests for the choice of a neuromuscular blocking agent after an anaphylactic reaction].
Dewachter P; Mouton-Faivre C; Pertek JP; Boudaa C; Mertes PM
Ann Fr Anesth Reanim; 2005 May; 24(5):543-6. PubMed ID: 15904734
[TBL] [Abstract][Full Text] [Related]
17. [Heart failure and anaphylactic shock. A report of two cases].
Verdier F; Petitjeans F; Griffet V; Caignault JR; Guerard S
Ann Cardiol Angeiol (Paris); 2011 Apr; 60(2):113-7. PubMed ID: 21277563
[TBL] [Abstract][Full Text] [Related]
18. Failure to investigate anaesthetic anaphylaxis resulting in a preventable second anaphylactic reaction.
Pedersen AF; Green S; Rose MA
Anaesth Intensive Care; 2012 Nov; 40(6):1053-5. PubMed ID: 23194216
[TBL] [Abstract][Full Text] [Related]
19. Cisatracurium-Associated Malignant Hyperthermia During Severe Sars-CoV-2 Infection.
Sathyanarayanan SP; Hamza M; Hamid K; Groskreutz D
Am J Ther; 2021 Aug; 28(5):e590-e591. PubMed ID: 34387563
[No Abstract] [Full Text] [Related]
20. Cisatracurium induces mast cell activation and pseudo-allergic reactions via MRGPRX2.
Che D; Rui L; Cao J; Wang J; Zhang Y; Ding Y; Zhao T; Ma P; An H; Gao Z; Zhang T
Int Immunopharmacol; 2018 Sep; 62():244-250. PubMed ID: 30032049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
